Learn how Atrium Health Wake Forest Baptist is using inventory optimization solutions to lower carrying costs and enhance dispensing workflows to realize better medication management outcomes.

A recent ruling by a Philadelphia federal appeals court could introduce more access and fulfillment barriers to specialty drugs for health systems that don’t have an in-house specialty pharmacy. Health systems need to consider a more holistic approach to pharmacy by adding in-house capabilities to their existing contract relationships.

Outdated processes for medication retrieval, controlled substance management, and compliance can contribute to nurse burnout, but dropping just one point from a hospital’s RN turnover rate can save as much as $262,300 per year.

During an ISMP-led symposium at the recent ASHP Midyear Meeting, Kevin Hansen, PharmD, Director of Pharmacy, Compounding Services at Cone Health in Greensboro, North Carolina, and Laura Mark, PharmD, VP of Pharmacy at Allegheny Health Network, shared their experiences with building successful sterile compounding strategies with IV automation.

Medication non-adherence is a crippling problem in healthcare today. In a recent session at ASHP Midyear, thought leaders from Omnicell Specialty Pharmacy Services and Bausch Health outlined how they were able to partner together to improve patient adherence to XIFAXAN, a specialty medication used to treat overt hepatic encephalopathy (OHE).

Ted Slafsky, publisher and CEO of 340B Report and Founder and Principal of Wexford Solutions, weighs in on midterm election results and their implications for the 340B drug pricing program.

We've missed connecting with our pharmacy and healthcare colleagues in person, and can't wait to see you In Las Vegas to share the new technology, insights, and services that are addressing the biggest challenges in medication management.

The U.S. Pharmacopeia (USP) published revisions to the general chapters on compounding Nonsterile <795> and Sterile <797> preparations, including robotic technology for the very first time. The latest revisions, which take effect November 1, 2023, exempt some robotic devices from surface sampling after every batch of Category 3 compounded sterile products (CSPs), and instead allow users of self-enclosed robotic devices to surface sample once per day. Sterile compounding is one of the most labor-intensive and risky areas of pharmacy. IV robotics have demonstrated proven benefits for safe, efficient sterile compounding for over 15 years, but market adoption has been slow.

Omnicell is celebrating its third Annual Compliance Week from November 7-11. Of note, this year also marks Omnicell's 30th anniversary. We have encouraged all of our employees to reflect upon how integrity has played an integral role in the growth of Omnicell throughout its 30-year history and how it will continue to be vital to every aspect of the company's future. We recognize our company would not be what it is today without integrity, and it remains an integral part of our continued success. In that spirit, our theme for Compliance Week 2022 is Integrity Inspires.

Omnicell and the Institute for Safe Medication Practices (ISMP) hosted an "Improving the Safe Use and Storage of Medications in the Perioperative Setting" symposium at the 2022 ANESTHESIOLOGY® Annual Meeting.

As we approach the 340B drug discount program's 30th anniversary on November 4, it is a good time to reflect on the key moments that have had the greatest impact on this very important program.

Simplifying medication retrieval and administration workflow allow nurses to focus on the patient, not the technology. When Omnicell partnered with Oracle Cerner for interoperability between the EHR and the XT Automated Dispensing System, the result was improved waste compliance, near 100 percent visibility of potential transaction discrepancies, and time savings for nursing and pharmacy.